PREPARATION AND INVITRO DISSOLUTION CHARACTERISTICS OF PROPRANOLOL MICROCAPSULES

被引：21
作者：
PONGPAIBUL, Y
WHITWORTH, CW
机构：
[1] UNIV GEORGIA,COLL PHARM,ATHENS,GA 30602
[2] CHIANG MAI UNIV,FAC PHARM,CHIANGMAI 50000,THAILAND
来源：
INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1986年 / 33卷 / 1-3期
关键词：
D O I：
10.1016/0378-5173(86)90059-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：243 / 248
页数：6
相关论文
共 16 条
[1]  
Baker R.W., 1974, CONTROLLED RELEASE B, P15
[2]   DISTRIBUTION OF PELLETS IN GASTROINTESTINAL-TRACT - INFLUENCE ON TRANSIT-TIME EXERTED BY DENSITY OR DIAMETER OF PELLETS [J].
BECHGAARD, H ;
LADEFOGED, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 (11) :690-692
[3]  
Beckett AH., 1982, DERMAL TRANSDERMAL A, P154
[4]  
BENET LZ, 1973, DRUG DESIGN, V4, P1
[5]   PHARMACOKINETICS OF PROPRANOLOL [J].
BORGSTROM, L ;
JOHANSSON, CG ;
LARSSON, H ;
LENANDER, R .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (04) :419-429
[6]   COMPARATIVE ORAL BIOAVAILABILITY OF CONVENTIONAL PROPRANOLOL TABLETS AND A NEW CONTROLLED ABSORPTION PROPRANOLOL CAPSULE [J].
BOTTINI, PB ;
CAULFIELD, EM ;
DEVANE, JG ;
GEOGHEGAN, EJ ;
PANOZ, DE .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1983, 9 (08) :1475-1493
[7]   LIDOFLAZINE AND PROPRANOLOL COMBINATION TREATMENT IN CHRONIC STABLE ANGINA [J].
CHARLAP, S ;
KIMMEL, B ;
BEREZOW, J ;
MOLINAS, S ;
STROM, J ;
WEXLER, J ;
WILLENS, H ;
KLEIN, N ;
POLLACK, S ;
FRISHMAN, WH .
ANGIOLOGY, 1985, 36 (04) :240-253
[8]   INVITRO DISSOLUTION OF PHENOBARBITONE SODIUM FROM ETHYL CELLULOSE MICROCAPSULES [J].
JALSENJAK, I ;
NICOLAIDOU, CF ;
NIXON, JR .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (12) :912-914
[9]   ONCE-DAILY PROPRANOLOL FOR HYPERTENSION [J].
LOPEZ, LM ;
GEFTER, ML ;
HEMMES, RJ .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (10) :812-815
[10]   PHARMACOKINETIC AND PHARMACODYNAMIC STUDIES WITH LONG-ACTING PROPRANOLOL [J].
MCAINSH, J ;
BABER, NS ;
SMITH, R ;
YOUNG, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (02) :115-121
12